Literature DB >> 26594670

Presence of Octopamine and an Octopamine Receptor in Crassostrea virginica.

Kerri Pryce, Dahniel Samuel, Elsie Lagares, Mathilde Myrthil, Fiana Bess, Ave Harris, Christopher Welsh, Margaret A Carroll, Edward J Catapane.   

Abstract

Octopamine is a biogenic amine first identified in octopus. It has been well studied in arthropods and a few gastropods, serving as a neurotransmitter and hormone. The presence of octopamine has rarely been reported in bivalves and has not been reported in Crassostrea virginica. We utilized HPLC to identify and measure octopamine in cerebral ganglia, visceral ganglia, gill, palps, mantle, heart and hemolymph of C. virginica. Endogenous octopamine levels increased when animals were treated with tyramine, an octopamine precursor. A preliminary study in our lab found that octopamine has a cardio-excitatory action on C. virginica heart. In the present study we also used immunoblotting techniques to identify an octopamine-like receptor (Pan TAAR, trace amine-associated receptor) in oyster heart. The study confirms the presence of octopamine in the nervous system, innervated organs and hemolymph of C. virginica and identifies the presence of an octopamine-like receptor in heart, strengthening the contention that octopamine is important in the physiology of C. virginica as it is in other invertebrates.

Entities:  

Year:  2015        PMID: 26594670      PMCID: PMC4652596     

Source DB:  PubMed          Journal:  In Vivo (Brooklyn)


  23 in total

Review 1.  Octopamine in invertebrates.

Authors:  T Roeder
Journal:  Prog Neurobiol       Date:  1999-12       Impact factor: 11.685

2.  Action of acetylcholine on bivalve hearts.

Authors:  M J GREENBERG; D A WINDSOR
Journal:  Science       Date:  1962-08-17       Impact factor: 47.728

3.  The effects of temperature acclimation on monoamine metabolism.

Authors:  G B Stefano; E J Catapane
Journal:  J Pharmacol Exp Ther       Date:  1977-11       Impact factor: 4.030

4.  The first family (adrenaline, noradrenaline, dopamine, octopamine, tyramine, phenylethanolamine and phenylethylamine).

Authors:  R J Walker; G A Kerkut
Journal:  Comp Biochem Physiol C       Date:  1978

Review 5.  Octopamine in invertebrates and vertebrates. A review.

Authors:  J C David; J F Coulon
Journal:  Prog Neurobiol       Date:  1985       Impact factor: 11.685

6.  The peripheral innervation of the gill of the marine mollusc demonstrated by the aluminium-formaldehyde (ALFA) histofluorescence method.

Authors:  E J Catapane
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

7.  Neurotransmitters in the nervous system of Macoma balthica (Bivalvia).

Authors:  T Karhunen; M S Airaksinen; L Tuomisto; P Panula
Journal:  J Comp Neurol       Date:  1993-08-15       Impact factor: 3.215

8.  Octopamine: presence in single neurons of Aplysia suggests neurotransmitter function.

Authors:  J M Saavedra; M J Brownstein; D O Carpenter; J Axelrod
Journal:  Science       Date:  1974-07-26       Impact factor: 47.728

9.  The nervous system control of lateral ciliary activity of the gill of the bivalve mollusc, Crassostrea virginica.

Authors:  Margaret A Carroll; Edward J Catapane
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2007-06-14       Impact factor: 2.320

10.  Oxidation of 5-hydroxytryptamine and related compounds by Mytilus gill plates.

Authors:  H BLASCHKO; A S MILTON
Journal:  Br J Pharmacol Chemother       Date:  1960-03
View more
  2 in total

1.  Cellular responses to in vitro exposures to β-blocking pharmaceuticals in hard clams and Eastern oysters.

Authors:  Bushra Khan; Robert M Burgess; Sandra A Fogg; Mark G Cantwell; David R Katz; Kay T Ho
Journal:  Chemosphere       Date:  2018-07-27       Impact factor: 7.086

2.  Molecular Characterization and Functional Analysis of a Putative Octopamine/Tyramine Receptor during the Developmental Stages of the Pacific Oyster, Crassostrea gigas.

Authors:  Peng Ji; Fei Xu; Baoyu Huang; Yingxiang Li; Li Li; Guofan Zhang
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.